Healthy volunteers sought for early safety test of experimental drug BEAM-103
Knowledge-focused
Recruiting now
This early-stage study tests the safety of a new drug called BEAM-103 in 30 healthy adults aged 18 to 55. Participants receive a single infusion of the drug or a placebo and are monitored for up to 4 months. The goal is to gather safety and dosing information, not to treat any di…
Phase: PHASE1 • Sponsor: Beam Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 02, 2026 07:07 UTC